Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients

Completed · Not applicable

Conditions studied: Ichthyosis, Pruritus

In brief

This study will test the safety and efficacy of three topical agents containing oat kernel flour to determine how well they relieve skin dryness and itching related to cancer therapies. Participants will receive a body wash, a body cream, and an anti-itch balm to use at home for 4-6 weeks.

Key facts

Study ID

NCT03796052

Run by

Johnson & Johnson Consumer Inc. (J&JCI)

People needed

53

Starts

2019-05-23

Expected to finish

2019-12-18

Last updated by the study team

2020-11-04

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• able to read, write, speak, and understand English
• has signed Informed Consent including Photograph Release
• has a prior diagnosis of a solid or hematologic tumor and either:
• is currently undergoing therapy with a systemic agent and has completed at least 3 cycles without severe skin reactions.
• has received therapy with a systemic agent in the past 28 days.
• is greater than 1 year status post allogeneic hematopoietic stem cell transplantation.
• is undergoing one or more types of cancer treatment that are commonly known to cause mild to moderate skin reactions such as rash, dryness, and/or itching
• is diagnosed with mild to moderate skin dryness (xerosis) and/or itching (pruritus).
• is capable of all self-care and is up and mobile at least 50% of the day
• intends to complete the study and is willing/able to follow all study instructions.

You may not qualify if…

• has known allergies or sensitivity to skincare products or study product ingredients.
• has other skin conditions or diseases that the investigator thinks would interfere with the study or put the subject at higher risk (e.g. immunosuppressive diseases, skin infections, etc.)
• has severe skin dryness, itching, or rash.
• is undergoing radiation therapy.
• is undergoing chemotherapy or adjuntive therapies known to commonly cause complex or severe skin reactions.
• has uncontrolled diabetes.
• is pregnant or planning to become pregnant during the study.
• is participating in another study for which the participant is receiving a treatment or therapy (observational studies are okay).
• is an employee or family member of the investigator, study site, or Sponsor.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.